These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2398744)

  • 1. Development and characterization of a lyophilized dosage form of IL-1 beta.
    Visor GC; Tsai KP; Miller MD; Duffy J; Calderwood T; Lokensgard D; Killian J; Malefyt T; Gu L; Massey I
    Lymphokine Res; 1990; 9(3):425-34. PubMed ID: 2398744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical development and characterization of an intravenous dosage form for the ACE inhibitor RS-10029.
    Visor GC; Lin LH; Henry P; Singer L
    J Parenter Sci Technol; 1989; 43(6):271-6. PubMed ID: 2600732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameters for the evaluation of IL-2 stability.
    Kenney WC; Watson E; Bartley T; Boone T; Altrock BW
    Lymphokine Res; 1986; 5 Suppl 1():S23-7. PubMed ID: 3491260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lyme disease spirochetes induce human and murine interleukin 1 production.
    Habicht GS; Beck G; Benach JL; Coleman JL; Leichtling KD
    J Immunol; 1985 May; 134(5):3147-54. PubMed ID: 2984284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
    Kenney JS; Masada MP; Eugui EM; Delustro BM; Mulkins MA; Allison AC
    J Immunol; 1987 Jun; 138(12):4236-42. PubMed ID: 2438338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of Russell's viper venom toxoid (lyophilized form) on storage.
    Aung W; Hlaing KK; Kyaw KP; Win MM; Kyaw A
    Jpn J Infect Dis; 1999 Dec; 52(6):234-7. PubMed ID: 10738360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of two neutralizing monoclonal antibodies to human interleukin-1 alpha.
    Stya M; Dower SK; Prickett KS; Gillis S; Conlon PJ
    J Biol Response Mod; 1988 Apr; 7(2):162-72. PubMed ID: 3258906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1.
    Mizel SB; Dukovich M; Rothstein J
    J Immunol; 1983 Oct; 131(4):1834-7. PubMed ID: 6352805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of human interleukin 1: isolation of a peptide fragment from plasma of febrile humans and activated monocytes.
    Dinarello CA; Clowes GH; Gordon AH; Saravis CA; Wolff SM
    J Immunol; 1984 Sep; 133(3):1332-8. PubMed ID: 6611371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature sensitivity of interleukin-dependent murine T cell proliferation: Q2 mapping of the responses of peanut agglutinin-negative thymocytes.
    Hanson DF; Murphy PA
    J Immunol; 1985 Nov; 135(5):3011-20. PubMed ID: 3876372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1 beta.
    Yem AW; Richard KA; Staite ND; Deibel MR
    Lymphokine Res; 1988; 7(2):85-92. PubMed ID: 3261381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of interleukin 1 by adult T cell leukemia (ATL) cell lines.
    Yamashita U; Shirakawa F; Nakamura H
    J Immunol; 1987 May; 138(10):3284-9. PubMed ID: 2883235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones.
    McKean DJ; Nilson A; Beck BN; Giri J; Mizel SB; Handwerger BS
    J Immunol; 1985 Nov; 135(5):3205-16. PubMed ID: 2413115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of thymocyte function by IL-2 as the only exogenous stimulus; analysis of two distinct modes of IL-2-induced thymocyte proliferation and IL-3 secretion in vitro.
    Bellio M; Dos Reis GA
    Immunology; 1989 Oct; 68(2):175-80. PubMed ID: 2807375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid biologic assay for the detection of interleukin 1.
    Conlon PJ
    J Immunol; 1983 Sep; 131(3):1280-2. PubMed ID: 6411811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin 1: purification and properties.
    Lachman LB
    Fed Proc; 1983 Jun; 42(9):2639-45. PubMed ID: 6602068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.